A Study to Show That the Change of Attention Measure is Correlated With the Changes of Caregiver's Burden After Treatment With Galantamine in Patients With Alzheimer's Disease

NCT01734395 · clinicaltrials.gov ↗

COMPLETED

Status

1882

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Galantamine

Sponsor

Janssen Korea, Ltd., Korea